Wednesday, June 22, 2022 6:45:32 PM
https://finance.yahoo.com/news/phoenix-motor-inc-announces-closing-195400611.html
They can do acquisitions with a combination of cash and stock. They might just be working on product, but if you look at all the other nontraditional motor groups other than TESLA, most of them have been sold off.
We can look at use of proceeds in the S-1 to see what they want to do with the money.
"We intend to use the net proceeds from this offering to invest in our technology, research and development efforts, manufacturing, marketing, obtain, maintain, expand our intellectual property portfolio and provide funding for working capital and other general corporate purposes. Pending specific utilization of the net proceeds as described above, we intend to invest the net proceeds of the offering in short-term investment grade and U.S. government securities."
R&D and "working capital and other general corporate purposes" ie management and consulting fees...
Recent PEV News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2024 01:07:17 AM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 02/29/2024 02:29:23 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/15/2024 09:07:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/08/2024 09:05:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 10:23:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 10:21:18 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/30/2024 02:20:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 09:52:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 02:27:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 12:59:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:05:27 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 11/27/2023 10:30:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2023 09:35:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 11:02:49 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/06/2023 10:12:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 09:18:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 05:17:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2023 07:47:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2023 08:10:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/28/2023 08:10:18 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM